Ischemic stroke represents one of the leading causes of death and disability in both the
United States and abroad, particularly for patients with prior ischemic stroke or transient …

Stroke recurrence continues to be the major risk for stroke survivors. Risk factor control and
antithrombotic medication are two major strategies for patients with a prior stroke or transient …

Stroke is a disease of the elderly and, as a result of the expected demographic changes in
many industrialised countries, its incidence is likely to increase in the future. A first-ever …

Background The current guidelines recommend various antiplatelet agents used alone or in
combination for secondary prevention of noncardioembolic stroke. Objective The purpose of …

Stroke is one of the leading causes of disability; most are due to atherothrombotic
mechanisms. About one third of ischemic strokes are preceded by other stroke or transient …

Abstract Purpose of Review Stroke is a leading cause of death and disability worldwide. The
annual incidence of new or recurrent stroke is approximately 795,000 cases per year in the …

Patients experiencing stroke or transient ischemic attack (TIA) are at high risk for recurrent
(secondary) strokes, which comprise 29% of all strokes in the United States. Current …

Stroke is a devastating condition with significant morbidity and mortality worldwide.
Antithrombotic therapy plays a crucial role in both primary and secondary prevention of …

The role of antithrombotic drugs in the prevention of cerebral infarction is well established:
antiplatelet drugs, at present mostly aspirin, clopidogrel, and aspirin+ extended-release …

Stroke is one of the leading causes of disability and death. Ischemic stroke is a syndrome
with heterogeneous mechanisms and multiple etiologies, rather than a singularly defined …